Navigation Links
Ingenuity Systems and Covance Collaborate to Support Next-Generation Sequencing Research
Date:2/23/2011

REDWOOD CITY, Calif., Feb. 23, 2011 /PRNewswire/ -- Ingenuity® Systems, a leading provider of information and analytics solutions for life science researchers, today announced a research collaboration with Covance Genomics Laboratory (www.covance.com/cgl) for next-generation sequencing (NGS) data analysis. Covance Genomics Laboratory, a leading provider of genomics solutions for the drug discovery and development industry, and Ingenuity will work together to develop new and novel approaches, using Ingenuity's IPA® software, to obtain more actionable insights from NGS data and to answer research questions in a relevant biological context.

This collaboration brings together leaders in genomics data production and analysis to develop new methodologies that integrate high-quality NGS data with industry-leading knowledge generation and management tools.  By working together to generate the next generation of biological interpretation tools, Covance Genomics Laboratory will have the unique ability to help its pharmaceutical clients maximize the value of their investment in NGS technologies.  IPA relieves the NGS data analysis bottleneck by providing the biological context necessary to move past the long noisy lists of genes, isoforms, and variants, helping to uncover those that are most critical to biology.  This enables researchers to quickly get to the intended high-value results of biomarker identification, target ID and validation, understanding drug mechanism of action, and safety assessment.

"We're delighted that Covance has selected IPA for its NGS workflows," said Doug Bassett, Ph.D., CSO and CTO, Ingenuity Systems. "We've been involved in several NGS collaborations recently, and our partnership with Covance, a leading drug development services company, represents another powerful validation of IPA's value in the NGS space. It is exciting to see IPA being used to accelerate and inform so much groundbreaking research."

Having run more than 450,000 samples to date, Covance Genomics Laboratory provides end-to-end services for genomics-based development research and has demonstrated particular expertise in NGS.  "The complexity of next-generation sequencing data can be a challenge to translational science and medicine," stated Tom Turi, Vice President, Science & Technology, Covance Discovery & Translational Services. "We're confident the combination of our best-in-class genomics data and the high-quality biological content and context provided by IPA will result in the delivery of more rapid, accurate, and thorough research services for our customers."  

About Ingenuity® Systems

Ingenuity Systems is a leading provider of information solutions and custom services for life science researchers, computational biologists and bioinformaticists, and life science industry suppliers. For more information visit: www.ingenuity.com


'/>"/>
SOURCE Ingenuity Systems
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Sigma-Aldrich Launches Your Favorite Gene Powered by Ingenuity
2. Sigma-Aldrich Honored With CIO 100 Award for Innovative Web Research Tool, Your Favorite Gene powered by Ingenuity
3. Ingenuitys Technology Powers BD Cell Pathways Tool on New BD Biosciences Website
4. Ingenuity Systems Announces New Distributor for Greece, Turkey and the Balkans
5. Ingenuity Systems Announces Toxicogenomics Best Practices White Paper
6. Ingenuity Systems and Sage Bionetworks Collaborate to Enable Predictive Disease Network Research
7. Ingenuity Systems and Erasmus University Medical Center Collaborate on Next-Generation Sequencing Project to Accelerate Disease Research
8. Pressure BioSciences, Inc. Releases Novel, PCT-dependent Sample Preparation Kit for Systems Biology Studies
9. North Dakota Pharmacists and Medication Management Systems Partner to Deliver Quality MTM Services to Patients With Diabetes
10. Avantis Medical Systems, Inc. Announces Key Leadership Appointments
11. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... MILFORD, Mass. , March 23, 2017 ... leading partner to global in vitro diagnostics ... launch of the industry,s first multiplexed ... inherited disease testing by next-generation sequencing ... materials were developed with input from industry ...
(Date:3/23/2017)... NetworkNewsWire Editorial Coverage  ... Cancer remains one of ... health care systems, in terms of costs and resources. However, ... the development of innovative and efficient therapies that demonstrate higher ... types of cancer treatments, a growing number of patients receiving ...
(Date:3/22/2017)... , March 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: ... Genetics Center (RGC), U.K. Biobank and GSK to generate genetic ... Biobank resource. The initiative will enable researchers to gain valuable ... for a wide range of serious and life threatening diseases. ... Genetic ...
(Date:3/22/2017)... March 22, 2017 Oramed Pharmaceuticals Inc. ... www.oramed.com ), a clinical-stage pharmaceutical ... delivery systems, announced today that Dr. Miriam ... a presentation titled, "Oral Insulin for Diabetes Treatment: ... Healthtech Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference in ...
Breaking Biology Technology:
(Date:3/16/2017)... , March 16, 2017 CeBIT 2017 - Against identity fraud with ... Reading ... Used combined in one project, multi-biometric solutions provide a crucial ... Used combined in ... ...
(Date:3/7/2017)... , March 7, 2017   HireVue , the ... global companies identify the best talent, faster, today announced ... Sales Officer (CSO) and Diana Kucer as ... out a seasoned executive team poised to drive continued growth ... on a year of record bookings in 2017. ...
(Date:3/2/2017)... , March 2, 2017 Australian stem ... (ASX: CYP), has signed an agreement with the ... the Monash Biomedicine Discovery Institute and Department of Pharmacology ... conduct a further preclinical study to support the use ... of asthma.  Asthma is a chronic, ...
Breaking Biology News(10 mins):